Management of disseminated kidney cancer

S. S. Taneja, W. Pierce, R. Figlin, A. Belldegrun

    Research output: Contribution to journalReview article

    Abstract

    The approach to disseminate renal cell carcinoma (RCC) has evolved significantly in recent years, largely owing to the progress of biologic therapy development. With increasing knowledge of biologic therapy come several dilemmas, including the choice of cytokine therapy, the appropriate mode of delivery, the selection of candidates for given therapeutic options, and the role of cytoreductive nephrectomy in immunotherapy protocols. This article reviews the historical development of immunotherapy and the lessons learned from previous experience and offers a logical approach to the patient with disseminated RCC.

    Original languageEnglish (US)
    Pages (from-to)625-637
    Number of pages13
    JournalUrologic Clinics of North America
    Volume21
    Issue number4
    StatePublished - Dec 12 1994

    ASJC Scopus subject areas

    • Urology

    Fingerprint Dive into the research topics of 'Management of disseminated kidney cancer'. Together they form a unique fingerprint.

  • Cite this

    Taneja, S. S., Pierce, W., Figlin, R., & Belldegrun, A. (1994). Management of disseminated kidney cancer. Urologic Clinics of North America, 21(4), 625-637.